Cargando…
Eradication of tumors and development of anti-cancer immunity using STINGa targeted by pHLIP
Despite significant progress in the development of novel STING agonists (STINGa), applications appear to be challenged by the low efficiency and poor selectivity of these agents. A pH Low Insertion Peptide (pHLIP) extends the lifetime of a STINGa in the blood and targets it to acidic cancer-associat...
Autores principales: | Moshnikova, Anna, DuPont, Michael, Visca, Hannah, Engelman, Donald M., Andreev, Oleg A., Reshetnyak, Yana K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622777/ https://www.ncbi.nlm.nih.gov/pubmed/36330464 http://dx.doi.org/10.3389/fonc.2022.1023959 |
Ejemplares similares
-
Tumor treatment by pHLIP-targeted antigen delivery
por: DuPont, Michael, et al.
Publicado: (2023) -
pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery
por: Crawford, Troy, et al.
Publicado: (2020) -
PET Imaging of Acidic Tumor Environment With (89)Zr-labeled pHLIP Probes
por: Bauer, David, et al.
Publicado: (2022) -
Arginine Residues Modulate the Membrane Interactions
of pHLIP Peptides
por: Silva, Tomás F. D., et al.
Publicado: (2023) -
Targeting diseased tissues by pHLIP insertion at low cell surface pH
por: Andreev, Oleg A., et al.
Publicado: (2014)